Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:ceased_operations |
1995
|
| gptkbp:countryOfOrigin |
gptkb:United_Kingdom
|
| gptkbp:foundedBy |
gptkb:Henry_Wellcome
gptkb:Silas_Burroughs |
| gptkbp:foundedYear |
1880
|
| gptkbp:headquartersLocation |
gptkb:London
|
| https://www.w3.org/2000/01/rdf-schema#label |
Burroughs Wellcome Company
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:mergedInto |
gptkb:Glaxo_Wellcome
1995 |
| gptkbp:notableAchievement |
development of acyclovir
development of antiretroviral drugs development of purine analogues |
| gptkbp:notableEmployee |
gptkb:George_H._Hitchings
gptkb:Gertrude_B._Elion |
| gptkbp:notableProduct |
gptkb:AZT_(zidovudine)
gptkb:Wellcome_Burroughs_Tabloid |
| gptkbp:successor |
GlaxoSmithKline
|
| gptkbp:bfsParent |
gptkb:George_H._Hitchings
|
| gptkbp:bfsLayer |
5
|